Bio:
Kari Trotter Wall,
Pharm.D. |
|
|
|
 |
Kari Trotter Wall, Pharm.D.
Dr. Kari Trotter Wall is pharmacy director at the University of Southern California Pharmacy. She serves as a mentor to pharmacy students and interns; as well as oversees pharmaceutical care services and screenings, including immunizations; emergency contraception; latent tuberculosis clinics; diabetes management and screening; hypertension, cholesterol and osteoporosis screenings; and brown bag medication review.
She also maintains a busy retail pharmacy, filling approximately 400 prescriptions per day; and is an adjunct professor for the school of pharmacy, lecturing in various pharmacy modules and helping facilitate in OTC small-group discussions.
Dr. Trotter Wall received a B.S. from the University of La Verne (1997). She received a Pharm.D. from the University of Southern California, where she also completed her community pharmacy residency.
Dr. Trotter Wall has maintained certification in basic life support since 1991 and adult immunizations since 2001. Since 2003, she has maintained certification in anticoagulation and basic physical assessment, has been involved in the emergency contraception program and has been a California State Board of Pharmacy registered pharmacist. In 2007, she became an American Pharmacist Association adult immunization trainer.
In addition, she is currently a member of several professional organizations, including the American Pharmaceutical Association, California Pharmacist Association, Phi Delta Chi Professional Fraternity, Skull and Mortar Service Fraternity, and American Society of Health System Pharmacists.
A true educator, Dr. Trotter Wall regularly lectures and gives presentations in California on various topics, including self-care and screening practices, medicine reviews, contraception, and smoking-cessation programs.
In December 2002, Dr. Trotter Wall contributed articles to several internal Pfizer publications, including Current FDA Approved Antifungals, Current FDA/EU Indication for Zovirax, Investigational Drugs to Treat Glaucoma and Investigational Drugs to Treat Age-Related Degeneration.
|
|
